|
Volumn 29, Issue 8, 2001, Pages 1519-1525
|
Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients
|
Author keywords
Cardiac index; Dobutamine; Enoximone; Hepatic function; Liver blood flow; Monoethylglycinexylidide; Septic shock; Tumor necrosis factor
|
Indexed keywords
DEETHYLLIDOCAINE;
DOBUTAMINE;
ENOXIMONE;
FENTANYL;
FLUNITRAZEPAM;
LIDOCAINE;
NORADRENALIN;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG METABOLISM;
FLUID THERAPY;
HIGH RISK PATIENT;
HUMAN;
INFLAMMATION;
INTENSIVE CARE UNIT;
LIVER BLOOD FLOW;
LIVER ISCHEMIA;
LIVER PERFUSION;
OXYGEN CONSUMPTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REPERFUSION INJURY;
SEPTIC SHOCK;
SPLANCHNIC BLOOD FLOW;
UNIVERSITY HOSPITAL;
|
EID: 0034883587
PISSN: 00903493
EISSN: None
Source Type: Journal
DOI: 10.1097/00003246-200108000-00004 Document Type: Article |
Times cited : (66)
|
References (53)
|